Posted by Alan Mittermaier
The delayed posting of the CY 2018 Medicare Marketing Guidelines on July 20th reveals only modest changes pertaining to Medicare Advantage/Part D website compliance. Areas involving new and existing compliance clarification include the following:
60.4 – Formulary and Formulary Change Notice Requirements (pp. 27-28)
60.4.3 – Changes to Printed and Posted Formularies (p.28)
Comment: Both of the above clarifications favor document eDelivery opt-in for plan members.
100.4 – Online Formulary, Utilization Management (UM), and Notice Requirements (p.71)
Comment: Previous online notification provisions become “must” requirements.
Comment: Includes new guidelines specifically for third-party websites defined as sites not owned by Plan/Part D sponsors, but by companies with whom Plan/Part D sponsors have contracts for the purpose of selling or promoting Medicare products.
Contact HealthMetrix Research president Alan Mittermaier for additional guidance related to 2018 website compliance and MedicareWebWatch evidence-based build-out strategies.